ENTRIGUE: Subcutaneous pegozafermin in severe hypertriglyceridaemia Presented ByProf. Deepak Bhatt, Harvard Medical School, MA, USA TrialPhase 2, ENTRIGUE ConferenceESC 2022 27 October, 2022 12:49